title: Expanding the applicability of noninvasive fibrosis markers in HIV/HCV co-infected patients.
authors.forename: Leonardo L
authors.initials: LL
authors.lastname: Schiavon
authors.forename: Roberto J Carvalho
authors.initials: RJ
authors.lastname: Filho
authors.forename: Janaína L
authors.initials: JL
authors.lastname: Narciso
authors.forename: Juliana P
authors.initials: JP
authors.lastname: Sampaio
authors.forename: Valéria P
authors.initials: VP
authors.lastname: Lanzoni
authors.forename: Maria Lucia G
authors.initials: ML
authors.lastname: Ferraz
authors.forename: Antonio Eduardo B
authors.initials: AE
authors.lastname: Silva
mesh_terms: D000367:Age Factors; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D015415:Biomarkers / Q000097:blood*; D015658:HIV Infections / Q000150:complications*; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood / Q000175:diagnosis* / Q000209:etiology* / Q000503:physiopathology; D010976:Platelet Count; D011379:Prognosis; D012720:Severity of Illness Index
chemical_list: D015415:Biomarkers; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase